CR Bard sharpens high-growth focus with Rochester buy
This article was originally published in Clinica
Executive Summary
CR Bard has set to buy Rochester Medical, a specialist of silicone urinary incontinence and urine drainage products, in a bid to capitalize on a growing near-$1bn market driven by the aging population.